[Signet ring cell carcinoma arising from mature cystic teratoma of the ovary].
Zheng
Hong-fang
HF
Jiang
Bao-yu
BY
Shen
Dan-hua
DH
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D018279:Carcinoma, Signet Ring Cell / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D002945:Cisplatin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007044:Hysterectomy; D053554:Keratin-20 / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D013724:Teratoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D053554:Keratin-20; D002945:Cisplatin